Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 39

1.

Expanding analytical options in sports drug testing: Mass spectrometric detection of prohibited substances in exhaled breath.

Thevis M, Krug O, Geyer H, Schänzer W.

Rapid Commun Mass Spectrom. 2017 Aug 15;31(15):1290-1296. doi: 10.1002/rcm.7903.

2.

lmplementation of the prolyl hydroxylase inhibitor Roxadustat (FG-4592) and its main metabolites into routine doping controls.

Eichner D, Van Wagoner RM, Brenner M, Chou J, Leigh S, Wright LR, Flippin LA, Martinelli M, Krug O, Schänzer W, Thevis M.

Drug Test Anal. 2017 Apr 4. doi: 10.1002/dta.2202. [Epub ahead of print]

PMID:
28378453
3.

Qualitative and Semiquantitative Analysis of Doping Products Seized at the Swiss Border.

Weber C, Krug O, Kamber M, Thevis M.

Subst Use Misuse. 2017 May 12;52(6):742-753. doi: 10.1080/10826084.2016.1263665. Epub 2017 Feb 3.

PMID:
28156209
4.

Identification of selected in vitro generated phase-I metabolites of the steroidal selective androgen receptor modulator MK-0773 for doping control purposes.

Lagojda A, Kuehne D, Krug O, Thomas A, Wigger T, Karst U, Schänzer W, Thevis M.

Eur J Mass Spectrom (Chichester). 2016;22(2):49-59. doi: 10.1255/ejms.1415.

PMID:
27419898
5.

Nickel in equine sports drug testing - pilot study results on urinary nickel concentrations.

Thevis M, Machnik M, Schenk I, Krug O, Piper T, Schänzer W, Düe M, Bondesson U, Hedeland M.

Rapid Commun Mass Spectrom. 2016 Apr 15;30(7):982-4. doi: 10.1002/rcm.7528.

PMID:
26969941
6.

Solutions Advertised as Erythropoiesis-stimulating Products were Found to Contain Undeclared Cobalt and Nickel Species.

Thevis M, Krug O, Piper T, Geyer H, Schänzer W.

Int J Sports Med. 2016 Jan;37(1):82-4. doi: 10.1055/s-0035-1569350. Epub 2016 Jan 7. No abstract available.

PMID:
26742015
7.

Seizures of doping substances at the Swiss Border--a descriptive investigation.

Weber C, Kamber M, Lentillon-Kaestner V, Krug O, Thevis M.

Forensic Sci Int. 2015 Dec;257:359-68. doi: 10.1016/j.forsciint.2015.10.001. Epub 2015 Oct 22.

PMID:
26517824
8.

In vitro metabolism studies on the selective androgen receptor modulator (SARM) LG121071 and its implementation into human doping controls using liquid chromatography-mass spectrometry.

Knoop A, Krug O, Vincenti M, Schänzer W, Thevis M.

Eur J Mass Spectrom (Chichester). 2015;21(1):27-36. doi: 10.1255/ejms.1328.

PMID:
25906032
9.

Detection of an unknown fusion protein in confiscated black market products.

Walpurgis K, Krug O, Thomas A, Laussmann T, Schänzer W, Thevis M.

Drug Test Anal. 2014 Nov-Dec;6(11-12):1117-24. doi: 10.1002/dta.1713. Epub 2014 Sep 14.

PMID:
25219942
10.

Identification of black market products and potential doping agents in Germany 2010-2013.

Krug O, Thomas A, Walpurgis K, Piper T, Sigmund G, Schänzer W, Laussmann T, Thevis M.

Eur J Clin Pharmacol. 2014 Nov;70(11):1303-11. doi: 10.1007/s00228-014-1743-5. Epub 2014 Aug 30.

PMID:
25168622
11.

Quantifying cobalt in doping control urine samples--a pilot study.

Krug O, Kutscher D, Piper T, Geyer H, Schänzer W, Thevis M.

Drug Test Anal. 2014 Nov-Dec;6(11-12):1186-90. doi: 10.1002/dta.1694. Epub 2014 Jul 17.

PMID:
25044557
13.

A family of "click" nucleosides for metal-mediated base pairing: unravelling the principles of highly stabilizing metal-mediated base pairs.

Richters T, Krug O, Kösters J, Hepp A, Müller J.

Chemistry. 2014 Jun 16;20(25):7811-8. doi: 10.1002/chem.201402221. Epub 2014 May 18.

PMID:
24838942
14.

Quantification of AICAR-ribotide concentrations in red blood cells by means of LC-MS/MS.

Thomas A, Vogel M, Piper T, Krug O, Beuck S, Schänzer W, Thevis M.

Anal Bioanal Chem. 2013 Dec;405(30):9703-9. doi: 10.1007/s00216-013-7162-0. Epub 2013 Jul 5.

PMID:
23828211
15.

Reply to: Pesch B, Weiss T, Pallapies D, Schlüter G, Brüning T. Letter to the editor. Re: Seidler A, Jähnichen S, Hegewald J, Fishta A, Krug O, Rüter L, Strik C, Hallier E, Straube S. Systematic review and quantification of respiratory cancer risk for occupational exposure to hexavalent chromium.

Seidler A, Jähnichen S, Hegewald J, Fishta A, Krug O, Rüter L, Strik C, Hallier E, Straube S.

Int Arch Occup Environ Health. 2013 Nov;86(8):961-3. doi: 10.1007/s00420-013-0888-3. Epub 2013 May 28. No abstract available.

PMID:
23712849
16.

Monitoring phosphodiesterase-4 inhibitors using liquid chromatography/(tandem) mass spectrometry in sports drug testing.

Thevis M, Krug O, Schänzer W.

Rapid Commun Mass Spectrom. 2013 May 15;27(9):993-1004. doi: 10.1002/rcm.6539.

PMID:
23592202
17.

Monitoring drug residues in donor blood/plasma samples using LC-(MS)/MS--a pilot study.

Thevis M, Krug O, Geyer H, Wenzel F, Bux J, Stahl L, Hollmann W, Thom A, Schänzer W.

Drug Test Anal. 2013 May;5(5):380-3. doi: 10.1002/dta.1457. Epub 2013 Jan 21.

PMID:
23338984
18.

The fungus Cunninghamella elegans can produce human and equine metabolites of selective androgen receptor modulators (SARMs).

Rydevik A, Thevis M, Krug O, Bondesson U, Hedeland M.

Xenobiotica. 2013 May;43(5):409-20. doi: 10.3109/00498254.2012.729102. Epub 2012 Nov 15.

PMID:
23153056
19.

Metabolism of growth hormone releasing peptides.

Thomas A, Delahaut P, Krug O, Schänzer W, Thevis M.

Anal Chem. 2012 Dec 4;84(23):10252-9. doi: 10.1021/ac302034w. Epub 2012 Nov 13.

PMID:
23101768
20.

Systematic review and quantification of respiratory cancer risk for occupational exposure to hexavalent chromium.

Seidler A, Jähnichen S, Hegewald J, Fishta A, Krug O, Rüter L, Strik C, Hallier E, Straube S.

Int Arch Occup Environ Health. 2013 Nov;86(8):943-55. doi: 10.1007/s00420-012-0822-0. Epub 2012 Oct 19. Review.

PMID:
23079792

Supplemental Content

Loading ...
Support Center